| Bentyl | |||
|
|
Search by color, shape and markings. click here
|
|
Check any 2 drugs for interactions. click here
|
|
|
Compare any two drugs side by side. click here
|
|
|
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
|
Has been used in the treatment of functional disturbances of GI motility such as irritable bowel syndrome.
Has limited efficacy in the treatment of these disorders and should be used only if other measures (e.g., diet, sedation, counseling, amelioration of environmental factors) have been of little or no benefit.
Has been used in combination with phenobarbital in the treatment of irritable bowel syndrome, but such combined therapy lacks substantial evidence of efficacy.
Has been used alone and in combination with phenobarbital in the treatment of acute enterocolitis†, but the drug alone and the combination lack substantial evidence of efficacy.
Has been used alone and in combination with phenobarbital in the treatment of infant colic†, but the drug alone and in combination lack substantial evidence of efficacy.
Considered a benign, self-limiting condition that tends to resolve spontaneously and not require medical treatment.
Administer orally or by IM injection.
Do not administer by IV or subcutaneous injection.
Usually administer orally.
Dilute oral solutions with an equal volume of water just prior to administration.
May be administered by IM injection when oral therapy is not feasible.
Oral therapy should replace IM therapy as soon as possible; do not use IM for longer than 1 or 2 days.
May produce local irritation and/or transient sensation of lightheadedness.
Available as dicyclomine hydrochloride; dosage expressed in terms of the salt.
Infants >6 months of age†: 5 mg 3 or 4 times daily.
Children†: 10 mg 3 or 4 times daily.
Usual initial dosage: 20 mg 4 times daily; limit IM to 1 or 2 days.
Maintenance: Depending on response, increase dosage during the first week to 40 mg 4 times daily unless adverse effects limit upward titration.
Only 40 mg 4 times daily has been shown clearly to be effective, but associated with a substantial incidence of adverse effects.
Discontinue the drug if an adequate response is not obtained within 2 weeks or adverse effects limit dosage to <80 mg daily.
20 mg 4 times daily; limit IM to 1 or 2 days.
Safety of 80–160 mg daily for longer than 2 weeks not established.
No specific hepatic dosage recommendations; use with caution.
No specific renal dosage recommendations; use with caution.
No specific geriatric dosage recommendations; use with caution since they may be more susceptible to adverse effects.
Last Updated: July 01, 2006Related Learning Centers |